Skip to main content
. 2023 Dec 17;15(12):e50703. doi: 10.7759/cureus.50703

Figure 1. Cancer-promoting molecular mechanisms and pathways potentially mediated by SARS-CoV-2 and/or certain COVID-19 vaccines.

Figure 1

SARS-CoV-2: severe acute respiratory syndrome coronavirus 2, COVID-19: coronavirus 2019, BRCA1/2: breast cancer 1/2, ACE2: angiotensin-converting enzyme 2, LNPs: lipid nanoparticles, RNA: ribonucleic acid, IFN: interferon